Caricamento...
Adiponectin Paradox as a Therapeutic Target in Alzheimer’s Disease
Despite the apparent neurotoxicity of amyloid-β (Aβ), recent clinical trials of Aβ immunotherapy have not shown any clinical benefit in Alzheimer’s disease (AD). Given this, clarification of the next generation therapeutic strategy in AD is warranted. Hypothetically, adiponectin might be involved in...
Salvato in:
| Pubblicato in: | J Alzheimers Dis |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
IOS Press
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7504987/ https://ncbi.nlm.nih.gov/pubmed/32623396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-200416 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|